Tscan Therapeutics, Inc. (TCRX) — DEF 14A Filings
All DEF 14A filings from Tscan Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
TScan Therapeutics Files Definitive Proxy Statement
— May 14, 2025 Risk: low
TScan Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on May 14, 2025, for its fiscal year ending December 31, 2024. The filing pertains to th -
TScan Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders on June 12, 2024
— Apr 30, 2024 Risk: low
TScan Therapeutics, Inc. (TCRX) filed a Proxy Statement (DEF 14A) with the SEC on April 30, 2024. TScan Therapeutics, Inc. will hold its 2024 Annual Meeting of
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX